Netris pancreatic cancer study doses first patient by John Pinching | Mar 29, 2023 | News | 0 Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials Read More
Positive results for Ipsen’s metastatic pancreatic cancer treatment by John Pinching | Nov 9, 2022 | News | 0 Onivyde regimen demonstrated statistically significant improvement in overall survival Read More